Nishikawa, Kazuhiro <br/><br/>
Impact of progression type on overall survival in patients with advanced gastric cancer based on randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatin.  [electronic resource] 

 -  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association  Jul 2017 
 - 640-645 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1436-3305 
<br/><br/><label>Standard No.: </label>10.1007/s10120-016-0666-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cisplatin--administration & dosage<br/>Disease Progression<br/>Disease-Free Survival<br/>Drug Combinations<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Organoplatinum Compounds--administration & dosage<br/>Oxaliplatin<br/>Oxonic Acid--administration & dosage<br/>Proportional Hazards Models<br/>Stomach Neoplasms--drug therapy<br/>Tegafur--administration & dosage